Clinical Trial Update: Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tislelizumab with chemotherapy or radiation as neoadjuvant therapy for esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 4 | Status: UNKNOWN